insights_auto
Outlook: 68.6% bullish·0.0% bearish
Go to analysischevron_right
EW:NYSE
Edwards Lifesciences Corp
103,10 US$
arrow_downward
-1,54%(-1,61) 1D
10 ნოე, 09:54:32 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
104,25 US$
High
104,58 US$
Low
103,10 US$
Mkt. cap
59,28 მლრდ.
Avg. vol.
4,48 მლნ.
Volume
146,81 ათ.
P/E ratio
58,45
52-wk high
104,58 US$
52-wk low
74,66 US$
EPS
1,76 US$
Beta
0,85
Shares outstanding
575,00 მლნ.
No. of employees
16 ათ.
Open
104,25 US$
High
104,58 US$
Low
103,10 US$
Mkt. cap
59,28 მლრდ.
Avg. vol.
4,48 მლნ.
Volume
146,81 ათ.
P/E ratio
58,45
52-wk high
104,58 US$
52-wk low
74,66 US$
EPS
1,76 US$
Beta
0,85
Shares outstanding
575,00 მლნ.
No. of employees
16 ათ.
News stories
From web sources and news partners
Trefis
·
7 საათის წინ
6 Green Days In A Row: Edwards Lifesciences Stock Is Up 14%
Investing.com Canada
·
17 საათის წინ
Form 144 Edwards Lifesciences Corp For: 9 November By Investing.com
News Corp
·
17 საათის წინ
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Investing.com
·
23 საათის წინ
Edwards Lifesciences stock rating maintained at Buy by TD Cowen
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 ათ.
Founded1958
Headquartersირვაინი, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryMedical device
Websiteedwards.com